Report Calls for Full Transparency on Trial Results, Indefinite Archiving of Master Files

International Pharmaceutical Regulatory Monitor
A A
Drugmakers should be required to maintain clinical trial master files indefinitely unless national legislation says otherwise, according to a draft report on the European Commission’s proposed clinical trials regulation. The information could be stored in the EU clinical trials database if necessary, it adds.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00